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Abstract: 
Pyrazinamide (PZA) - an important drug in the anti-tuberculosis therapy, activated by an enzyme Pyrazinamidase (PZase). The basis of PZA 
resistance in Mycobacterium tuberculosis was owing to mutation in pncA gene coding for PZase. Homology modeling of PZase was performed 
using software Discovery Studio (DS) 2.0 based on the crystal structure of the PZase from Pyrococcus horikoshii (PDB code 1im5), in this study. 
The model comprises of one sheet with six parallel strands and seven helices with the amino acids Asp8, Asp49, Trp68, Lys96, Ala134, Thr135 
and Cys138 at the active site. Five mutants were generated with Gly at position 8, Thr at position 96, Arg at position 104, Tyr and Ser at position 
138. The Wild-type (WT) and five mutant models were docked with PZA. The results indicate that the mutants Lys96Thr, Ser104Arg Asp8Gly 
and Cys138Tyr may contribute to higher level drug resistance than Cys138Ser. These models provide the first in-silico evidence for the binding 
interaction of PZA with PZase and form the basis for rationalization of PZA resistance in naturally occurring pncA mutant strains of M. 
tuberculosis. 
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Background: 
Despite being a controllable, preventable and curable disease, 
Tuberculosis (TB) still remains as a major public health problem in 
many parts of the world. The recent increase in multi-drug resistant 
(MDR-TB) and extensively drug resistant (XDR-TB) has further 
worsened the situation. Drug resistance in TB is essentially a potential 
threat to the TB control programmes. Genetic and molecular analysis 
of drug resistance in M. tuberculosis suggests that the bacilli usually 
acquire resistance either by alteration of the drug target through 
mutation or by titration of the drug through overproduction of the 
target. PZA is an important sterilizing drug and a principle component 
in the current six-month short course TB-chemotherapy. PZA plays a 
unique role in shortening the therapy from a period of 9 to 12 months 
down to 6 months, because PZA kills a population of semi dormant 
tubercle bacilli, residing in an acidic environment, which cannot be 
killed by other TB drugs [1].  
 
In M. tuberculosis, the susceptibility to PZA correlates with the 
presence of a single enzyme with nicotinamidase and pyrazinamidase 
activities. Strains of M. tuberculosis that are resistant to PZA are often 
defective in PZase activity [2].  PZA-resistant (PZAr) M. tuberculosis 
clinical isolates are usually defective for PZase activity, and there is 
very good correlation between PZA resistance and loss of this enzyme. 
Scorpio and Zhang in 1996 had identified the PZase gene (pncA) from 
M. tuberculosis and had shown that pncA mutations are a major 
mechanism of PZA resistance [3]. The identified pncA mutations are 
largely missense mutations causing amino acid substitutions, and in 
some cases nucleotide insertions or deletions and nonsense mutations 
in the pncA structural gene or in the putative promoter region of pncA 
[4]. The uniqueness in the mutations of pncA gene is its diversity and 
scattering along the whole gene though there does appear to be some 
degree of clustering at three regions of PncA protein (3 to 17, 61 to 85, 
and 132 to 142). These regions are likely to contain catalytic sites for 
the PZase enzyme [5]. PZA as a prodrug needs to be activated by the 
bacterial nicotinamidase-PZase into pyrazonic acid (POA), the active 
moiety of the drug [3]. 
 
A study [6] depicting the structure-function relationships of PncA 
protein (PZase) has clearly shown that the decrease in PZase activity 
observed in the mutant proteins correlates well with the structural 
modifications. However, the report also emphasizes the need for 
further structural studies to validate the positioning of the catalytically 
important amino acid residues (Asp8, Asp49, Lys96, Trp68, Ala134, 
Thr135 and Cys138). Although the report has provided both kinetic 
and structural data related to nine different mutants of PZase in 
connection to Cys138 a putative active site residue, but it did not 
provide any information regarding the mutants of Cys138. In another 
recent report [7] comprehensive enzymatic characterization of PZase 
was carried out with the generation of nine different mutants. It 
suggested that the Asp8, Lys96 and Cys138 were key residues for 
catalysis and Asp49, His51, His57 and His71 were essential for metal 
ion binding, this report too demanded the need to promote structural 
studies. In the light of which, we therefore have made an attempt to 
develop a three dimensional (3D) model of PZase along with the 
generation of five mutant models with Cys138Ser, Cys138Tyr, 
Asp8Gly, Lys96Thr and Ser104Arg and in the process, to explore its 
interactions with PZA. Out of the five, two (Cys138Ser and 
Cys138Tyr) were created in our study whereas the other three mutants 
Asp8Gly, Lys96Thr and Ser104Arg were created on the basis of prior 
kinetic studies. In addition, a basic analysis was performed to 
determine the correlation between kinetic and the docking data based 
upon the above-mentioned studies.  
 
Methodology: 
Homology modeling of PZase: 
Homology modeling helps in predicting the 3D structure of a 
macromolecule with unknown structure (target) by comparing it with a 
known template from another, structurally highly similar, 
macromolecule. The sequence of PZase from M. tuberculosis was 
searched against PDB (Protein databank) using PSI-BLAST (Basic 
Local Alignment Search Tool) [8] program to identify the related 
protein structure to be used as a template. The X-ray structure of 
PZase (PDB code, 1im5) from Pyrococcus horikoshii (P. horikoshii) 
was chosen as the template for the modeling PZase of M. tuberculosis 
(SWISSPROT accession no. Q5UFH2). Sequence and structural 
alignment of 1im5 and 2hor with PZase sequence was performed using 
ClustalW [9] and MSDFOLD. Aligning was carried out carefully 
without insertion of any gaps in the conserved secondary structural 
regions. From the alignment, spatial restraints were derived and used 
in the 3D model construction with MODELLER (Discovery Studio; 
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Accelrys). The stereochemical quality of the model structure was 
analyzed with RAMPAGE program using Ramachandran plot [10]. 
This model was further used for the identification of active site and for 
docking with PZA.  
 
Modeling of mutant PZase was similar to the WT showing 99% 
similarity owing to change in single amino acid. Sequence alignment 
of WT with the five mutant sequences was performed using ClustalW 
(see supplementary materials available with authors).  
 
Active site analysis of PZase enzyme: 
The active site of PZase from M. tuberculosis was analyzed using DS 
package. To identify a binding site, the receptor is first mapped to a 
grid. Grid points within a given distance of a receptor atom are marked 
as occupied by the receptor, and thus designated as undesirable 
locations for ligand atoms. The remaining unoccupied grid points are 
used to define the binding site (See supplementary material available 
with the authors for procedure to analyze active site) [11]. 
 
Docking of PZA-PZase: 
 Docking was performed using CDOCKER. The CDOCKER protocol 
is an implementation of the CDOCKER algorithm [12] in the DS 
environment. It allows running a refinement docking of any number of 
ligands with a single protein receptor. CDOCKER is a grid-based 
molecular docking method that employs CHARMm. The ligand was 
added with H (Hydrogen) atoms using DS. The models were energy 
minimized with CHARMm force field and metal ion Zn was added 
before performing docking. The receptor is held rigid while the ligands 
are allowed to flex during the refinement. Docking was performed 
using the default settings. The default speed selection was used to 
avoid a potential reduction in docking accuracy.  
 
 
Figure 1: (a) Three-dimensional model of PZase. (b) A TOPS cartoon of PZase model. Strands are shown in yellow triangles and helices in red 
circles. The direction of elements can be deduced from the connecting lines. `Up' strands are indicated by upward pointing triangles. 
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Figure 2: (a) Superimposition of binding residues of WT (Cys138) and mutant (Tyr138) model. (b) Superimposition of binding residues of WT 
(Cys138) and mutant (Ser138) model. 
 
Discussion: 
Homology modeling of PZase:  
In the results of BLAST search against PDB, 1im5 and 2hor were 
identified as template and reference proteins respectively. 3D-PSSM 
algorithm was used for fold recognition analyses by threading and 
provided similar results to that of BLAST. PZase of P. horikoshii 
(1im5), a member of α/β isochorismatase-like hydrolases family, 
having high level sequence identity of 37%, was chosen as a template 
for modeling PZase of M. tuberculosis. Previously, a study [6] 
provided structural details about the of PZase on the basis of model 
obtained from Arthrobacter CSHase as template which had sequence 
homology of about 26%, whereas in the present study the chosen 
template showed 37% identity; indicating a greater degree of 
reliability. In general, 30% sequence homology is required for 
generating useful models.  
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Secondary structure of PZase was predicted using JPRED. Amino acid 
sequence of the target was aligned to the template sequence based on 
the secondary structure information for building an accurate model. 
Structurally conserved regions (SCRs) for the target sequence and the 
templates were determined by superimposition of two structures and 
multiple sequence alignment. Coordinates from the reference protein 
(1im5) to the SCRs, structurally variable regions (SVRs), N-termini 
and C-termini were assigned to the target sequence based on the 
satisfaction of spatial restraints. The initial model was thus generated 
with the above procedure. On the basis of PFAM analysis it was found 
that the model contains isochrismatase domain (residues 2-185) 
consisting of seven α-helices and six strands of a parallel β-sheet, 
which is similar to those in alpha and beta (a/b) proteins. The 3D 
structure of PZase is as shown in Figure 1a. The connectivity between 
the secondary structures is represented in TOPS diagram (Figure 1b).  
 
Validation of PZase: 
The models were validated using Ramachandran plot. For the WT, a 
total of 94.5 % of the residues were in favored region.   The number of 
favorable region residues for the mutants viz., Asp8Gly, Lys96Thr, 
Ser104Arg, Cys138Tyr and Cys138Ser are 95.1, 96.7, 96.2, 93.4, and 
94.5% respectively (see supplementary material for Figures). 
 
Superimposition of 1IM5 with PZase enzyme: 
The 3D structures of PZase (final model) was superimposed with 1im5 
and 2hor using MSDFOLD (refer supplementary material for figures). 
Based on the above analysis, it was evident that the secondary 
structures were highly conserved among the three proteins but 2hor 
showed 25 residues (forming two antiparallel strands) insertion 
between βB and α3. The weighted root mean square deviation 
(RMSD) for 2hor was 1.4 Å with PZase. The RMSD of Cα trace 
between 1im5 and PZase was 0.5 Å with a Z score of 7.0 supporting 
that 1im5 is the right template for modeling PZase protein.  
 
The mutant models obtained was also validated using the 
Combinatorial Extension (CE) method. The structural alignment was 
performed for the WT and mutant models and was indicative of good 
structural alignment (99.5%) due the change in single amino acid. The 
3D structures of WT and mutants were also superimposed. The RMSD 
score was calculated using the sequence identity and gaps in the 
alignment. The RMSD value of 0.1 Å and Z-score of 7.3 was shown 
for the mutants Asp8Gly, Lys96Thr and Ser104Arg, and for the 
mutants Cys138Tyr and Cys138Ser the values were of 0.6 Å and 1.0 Å 
respectively (see supplementary materials available with the authors). 
 
Active site analysis of PZase: 
The final model was analyzed for identifying the possible binding sites 
of PZase using binding site tool in DS and Qsite finder tool [13].  Six 
binding sites were identified using DS. Out of 6 sites, site one was 
considered as active site consisting of Asp8, Phe13, Asp49, Trp68, 
Lys96, Ser104, Ala134, Thr135 and Cys138, which was found to be in 
concordance with the earlier reports   [6, 7]. Of these, Asp8 occur 
within the loop region connecting βA and α1, Phe13 within α1, Asp49 
within βB, Trp68 within 20 residues long loop connecting α3 and α4, 
Lys96 emerge from βC, Ala134 and Thr135 within loop region 
connecting βB and α6. Ser104 emerge form the loop connecting βC 
and α5. The putative active site residue Cys138, which is highly 
conserved, is located within α6 region of the model. Hence, site one 
was chosen as the most favorable binding site for exploring the 
interaction with drug molecule. 
 
Mutated models: 
In this study, PZase was modeled using the DS 2.0 and the models 
were constructed based on the sequence of pncA gene for WT and five 
mutants Asp8Gly, Lys96Thr, Ser104Arg, Cys138Tyr and Cys138Ser 
(refer supplementary materials available with the authors). No 
significant conformational change was observed in the structure of the 
mutant models Lys96Thr and Ser104Arg whereas in the mutant 
Asp8Gly changes were detected at Lys96 (a key active site residue). 
Mutated model with Cys138Tyr substitution imparted certain 
conformational changes at the active site with deviation in the side 
chain of residues viz., Asp49, Trp68 and Lys96. Structural evaluation 
with RAMPAGE showed a decrease in number of residue in the most 
favored region (93.4%). Model structure with Cys138Ser substitution 
also produced some degree of conformational changes at the active 
site. Structural evaluation showed 94.5% residues in the most favored 
region using RAMPAGE using (see supplementary material). 
Superimposition of WT with mutant (Asp8Gly, Lys96Thr and 
Ser104Arg) models using CE implies that there was a little degree of 
deviation from the WT (on the basis of RMSD score of 0.1 Å); hence 
the change in single amino acid did not produce any significant change 
in the overall conformation of the protein. In case of mutants such as 
Cys138Tyr and Cys138Ser (0.6 Å and 1.0 Å) the deviation was more 
pronounced affecting the conformation drastically, this was quite 
apparent in Cys138Ser model (refer supplementary material available 
with authors). Superimposition of binding residues of WT (Cys138) 
with mutant (Tyr138) and (Ser138) models are shown in Figure 2a and 
Figure 2b respectively.  
 
Docking of PZA-PZase:  
All the six models were flexibly docked with PZA using CDOCKER. 
Of the ten poses produced, the best ligand pose was selected based on 
CDOCKER top score and the target structure was selected for further 
analysis. The ligand poses were analyzed and a heat map was 
produced to count H bonds made by the poses to the receptor molecule 
and count close contacts (van der Waals clashes) between the poses 
and receptor molecule. No van der Waals clashes were seen between 
the PZA and model structure (data not shown). Docking results 
indicate that conserved amino acid residue (Cys138) in PZase play an 
important role in maintaining a functional conformation and directly 
involved in drug donor binding. 
 
Interaction of the drug molecule with mutated models was also studied 
on the basis of H bonding.  As it is well known, H bonds play an 
important role for the structure and function of biological molecules, 
especially for the enzyme catalysis. The H bonds present in the 
enzyme-drug complex along with their distances are shown in Figure 
3a. In this study, it was found that mutated model with Cys138Tyr 
forms five H bonds:  3 with Asp49, 1 with His71 and 1 with Ala102. 
The mutated model with Cys138Ser forms three H bonds with Asp49.  
The mutated model with Asp8Gly forms three H bonds. There 
occurred no H bond formation during the docking process for the 
mutants Lys96Thr and Ser104Arg. WT model with Cys138 forms four 
H bonds: Three H bonds were identified to form with Asp49 and one 
H bond with Ala102 these are important for strong interactions with 
the drug. The PZA-PZase complex was visualized using DS in order to 
get insight into the interaction between the drug and target. Surface 
representation of model structure with PZA docked into the cavity is 
shown in Figure 3b.   It is evident from the figure that PZA is located 
in the center of the active site, and is stabilized by H bonding 
interactions. The drug is bound between α1- α4 alpha helices and βA – 
βD beta strands. The binding energy between the enzyme and drug 
was found to be -27.9397 kcal/mol. The electrostatic and Van der 
Waals energies were -5.48845 and -3.35432 kcal/mol respectively. It 
can be speculated that the conformational changes which occurs due to 
mutations at the active site of target protein, causes alteration in the 
drug binding ability of the protein. At instances when the mutations 
are severe, the binding ability gets diminished resulting in survival of 
the organism in the presence of drug, leading to drug resistance.  
 
According to the inverse relationship between the binding affinity of 
drug and drug resistance (higher the affinity-lower will be the 
resistance). It can be pointed out that docking, although an important 
parameter to judge the affinity of protein (high score leads to high 
affinity) towards the ligand, cannot be considered as a sole factor for 
the determination of binding affinity.  In the present context it has 
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provided the results contrary to the prior kinetic studies. The mutants 
Lys96Thr and Ser104Arg displayed a similar and low docking value (-
7.21 kcal/mol) indicating lower affinity hence may contribute to high-
level drug resistance, is in agreement with the reported [6, 7] kinetic 
data showing no activity and conferring high degree of resistance. On 
the contrary, the mutant with Asp8Gly conversion showed relatively 
high docking value (-16.51 kcal/mol) suggesting its higher affinity 
towards the drug molecule leading to low-level drug resistance in 
concordance with the report [7] showing higher activity, but in sharp 
opposition with the report [8] with virtually no activity. The mutated 
model with substitution of Cys to Ser at position 138 showed higher 
value (-19.18 kcal/mol) compared to Cys to Tyr model (-17.75 
kcal/mol). Therefore, Cys to Tyr substitution may lead to higher 
degree of PZA resistance than Cys to Ser.  
 
 
Figure 3: (a) PZA docked with PZase. The dotted line represents H bonds with Asp49. (b) Surface representation of model structure with PZA 
(shown in red stick form) docked into the cavity. The residues surrounding the active site are colored yellow. Surface color red and blue 
represents electro negative and electro-positive. 
Bioinformation  open access 
www.bioinformation.net  Hypothesis
 
   
ISSN 0973-2063 (online) 0973-8894 (print)   
Bioinformation 4(1): 24-29 (2009)  © 2009 Biomedical Informatics 
 
29
The mutant models Lys96Thr and Ser104Arg showed significantly 
lower score (60%) compared to WT value (-17.95 kcal/mol). The 
models Asp8Gly and Cys138Tyr displayed a low score of 9% and 2% 
respectively. However the mutant Cys138Ser presented higher score 
(7%) compared to WT and others. Overall the interaction between the 
WT and mutant models with the drug indicates differences in the 
binding ability, with the WT values being higher than the mutants such 
as Lys96Thr, Ser104Arg, Asp8Gly and Cys138Tyr and lower than 
Cys138Ser. Thus it can be hypothesized that the above mutants may 
contribute to high-level drug resistance in the following descending 
pattern: Lys96Thr/Ser104Arg >Asp8Gly >Cys138Tyr >Cys138Ser. 
 
Conclusion: 
With the help of predicted models, the conformational changes due to 
mutations at the active site residues were determined. On the basis of 
docking score, it can be interpreted that the steric constraints resulting 
from such mutations could significantly alter the folding of the mutant 
protein and or the positioning of the side chain of the catalytic 
residues.  This may readily explain the loss of PZase activity thereby 
inhibiting the conversion of PZA to POA. Also, how point mutations 
can dramatically alter the ability of drug binding which eventually 
may lead to differences among the WT and mutants. Thus, we suggest 
that the mutant Cys138Ser represented with high docking score may 
contribute to low-level drug resistance than other mutants. The 
findings suggest that redesign of the PZA molecule to improve drug 
binding may be a viable approach to overcome resistance in PZase 
especially for mutant with Lys96Thr, Ser104Arg andAsp8Gly 
substitutions.  Such studies will be helpful in better understanding 
about the mechanism of drug resistant. Detection of mutations at the 
active site of the target protein enables to gain novel insight into the 
drug-target interactions, leading to the rational design of more 
efficacious wonder drugs that not only shorten TB-therapy but also 
can prevent the emergence of drug resistance. 
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